|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01092494 |
|
Date of registration:
|
23/03/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Postoperative Cyclic Oral Contraceptive Use for the Prevention of Endometrioma Recurrence
|
|
Scientific title:
|
Efficacy of Postoperative Cyclic Oral Contraceptive Use After Gonadotropin-releasing Hormone Agonist for the Prevention of Endometrioma Recurrence |
|
Date of first enrolment:
|
March 2010 |
|
Target sample size:
|
232 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01092494 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Retrospective
|
|
|
Countries of recruitment
|
|
Korea, Republic of
| | | | | | | |
|
Contacts
|
|
Name:
|
DooSeok Choi |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
dooseok.choi@samsung.com |
|
Affiliation:
|
|
|
|
Name:
|
DooSeok Choi, MD, PhD |
|
Address:
|
|
|
Telephone:
|
82-2-3410-3514 |
|
Email:
|
dooseok.choi@samsung.com |
|
Affiliation:
|
|
|
|
Name:
|
DooSeok Choi |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Samsung Medical Center |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. reproductive aged women who underwent conservative laparoscopic ovarian surgery for
endometrioma (ASRM stage III/IV) which was confirmed by pathologic inspection
2. women who were given postoperative GnRHa injections every 28 days for 3 or 6 months
3. women with no residual lesion confirmed by ultrasonography after surgery
4. women who were followed up for over 12 months after surgery.
Exclusion Criteria:if they had
1. undergone hysterectomy during an operation
2. been given GnRHa injections more than 6 times
3. been given other types of postoperative treatment (progestin or intrauterine device)
4. a history of previous pelvic surgery for endometriosis
5. a history of hormonal treatment before surgery
6. been diagnosed as menopause after surgery
7. contraindications to OCs
8. been identified ovarian endometriomas within 6 months of postoperative evaluation
Age minimum:
15 Years
Age maximum:
49 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Endometriosis
|
|
Primary Outcome(s)
|
|
recurrence rate of endometrioma
[Time Frame: 60 months]
|
|
Secondary ID(s)
|
|
2010-02-020
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|